The Christie Foundation Trust Annual Report and Accounts 2021-22

The Christie NHS Foundation Trust Annual Report and Accounts 2021-22

Haematology

This year saw continued developments in the Haematology service with new complex treatments as well as new targeted treatments, which has resulted in the service adapting quickly while maintaining high standards of care. Like all services, there have also been changes to services required as a result of the COVID-19 pandemic. Our Haematology service provides inpatient, ambulatory, day case, apheresis and outpatient services in dedicated facilities at The Christie site. Haematology@Services In December 2021, the Haematology service provided by The Christie opened at Macclesfield to become our second full haematology @service, in addition to the Tameside service. The new Macclesfield service will provide expert local Haematology service to the population of East Cheshire, North Staffordshire and High Peak.

patients. However, this is expected to resume again as restrictions lift and there are plans for new protocols for ambulatory care in 2022.

CAR-T/Transplant Despite adjustments that were required to safely manage high risk transplant patients during COVID-19, transplant activity has remained steady overall with the CAR-T service growing. This is expected to grow further in 2022/23 as new products become licenced.

Palatine Ambulatory care Our dedicated ambulatory care facility is for haematology and TYA patients undergoing treatments via 24 hour infusion pumps to enable them to have treatment at home or in a home like environment. This facility opened in November 2018 and has now treated over 530 patients. Due to COVID-19 restrictions, the growth in activity through ambulatory care has slowed, in particular with relation to transplant

13